Some 61 percent of California voters this week showed they still believe in the economic promise of clean energy. Californians rejected Proposition 23 that would have rolled back policies to limit greenhouse gas emissions and develop clean energy. Their vote of confidence reminds us that even though comprehensive federal climate legislation may be off the … Continue reading “Cap-and-Trade May Be Wounded, But The Low Carbon Economy is Still Healthy”
Author: Rogers Weed
Rogers Weed was appointed by Gov. Chris Gregoire as Director of the Department of Commerce in March 2009. In appointing him to this agency cabinet position, Gov. Gregoire said Rogers is a proven leader and innovator. As director, Rogers will fulfill the governor’s clear mission to retain the jobs and companies that we have in our state today and attract new ones. His focus will be on forging effective partnerships with the business community, with other agencies in the public sector and with the legislature.
Rogers attended Duke University where he graduated Magna Cum Laude with a degree in Computer Science. After college he worked for the management consulting firm, Bain and Company in Boston, focusing on strategy and planning for companies in the pharmaceutical, manufacturing and high tech industries. Rogers received his MBA in Marketing from the Wharton School at the University of Pennsylvania. He came to Seattle in 1990 to work at Microsoft and managed teams in the Windows, Mobile Devices, On-line Content and Consumer Software Divisions over his 15 years with the company. He was promoted to Vice President in 2001. Rogers has been a board member and volunteer for regional organizations focused on climate change and social services. He lives in Seattle with his wife and three sons.
Invest in Biotech, Or Watch the U.S. Health Innovation Edge Slip Away
Not everyone understands the way that new medical treatments, diagnostics, medicines, therapies and the like are created. It’s a long, expensive process, mostly the realm of scientists and engineers. But anyone who’s ever been concerned about a sick family member, or a loved one succumbing to disease, can appreciate what these scientists and their discoveries … Continue reading “Invest in Biotech, Or Watch the U.S. Health Innovation Edge Slip Away”